Lecture Xv Arteriosclerosis And Atherosclerosis 11

Post on 24-May-2015

2,000 views 2 download

Tags:

transcript

Arteriosclerosis

and

Atherosclerosis

Problems With Oxygen

Transport

LIPIDS = FATS

TRIGLYCERIDES

PHOSOPHOLIPIDS

STEROIDS

CHOLESTEROL

Wax like substance

Structural component of

cell membranes

Hormones, Vit D, Bile Acids

Produced in Liver

Serum Lipids

HDL

High density lipids

“good cholesterol”

Protective effect against atherosclerosis

LDL

Low density lipids

“bad cholesterol”

Increased incidence of atherosclerosis

VLDL

Very low density lipids

Transport triglycerides

Increase risk of premature atherosclerosis

TRIGLYCERIDES

Stored body fat

Serum Lipids

Arteriosclerosis

Hardening and of elasticity

of arterial walls

Most common arterial

disease

Normal aging process

Hypertension

Diabetes

Atherosclerosis

Formation of obstructive lipid deposits

Affects arteries

Lipid metabolism disorder

Obstruction of blood flow organs

Underlying cause of CAD, MI,

CVA, aneurysms and arterial

vascular disease

Normal and

atherosclerotic arteries

ETIOLOGY

AGE & SEX

GENETICS

PRE EXISTING CONDITIONS

SMOKING

DIET

EXERCISE OR LIFE STYLE

ATHEROSCLEROTIC LESIONS

Fatty streak

Raised fibrous plaque

Atheroma - irreversible

Commonly Affected Sites

Coronary arteries

Vascular bifurcations or

branch areas

Abdominal aorta

Iliac arteries

Femoral arteries

Progression of

Atherosclerosis

INCIDENCE & RISK

MALE vs FEMALE UNTIL MENOPAUSE

BLACK vs WHITE IN MEN AND WOMEN

FAMILY PREDISPOSITION

HIGH SERUM LIPIDS

SMOKING

OBESITY - LIFESTYLE

PRE EXISTING CONDITIONS

RISK FACTORS

HIGH SERUM LIPIDS

SMOKING

OBESITY - LIFESTYLE

PRE EXISTING CONDITIONSHTN

DIABETES

ATHEROSCLEROSIS

SERUM LIPID STUDIES

WHAT DO MY

CHOLESTEROL LEVELS MEAN???

AMERICAN HEART ASSOCIATION

HANDOUT

MANAGEMENT

Dietary FATS

Saturated

Polyunsaturated

Monounsaturated

Hydrogenated

HX & NUTRITIONAL FACTS

Calories vs. Fats

Cooking recommendations

Alcohol consumption

Exercise

DRUG THERAPY

Statins: Lipitor, Zocor

HMG-COA Reductase Inhibitors:

Mevacor

Bile acid sequestrants: Questran

Nicotinic Acid: Niacin

Fibric Acids: Atromid, Lopid

Vessel spasm

Tachycardia

Blood diseases

Bradycardia

FACTORS THAT O2 SUPPLY

TO THE

Heart rate increase

Contractibility

Afterload

Hypertrophy of Left

Ventricle

FACTORS THAT O2 DEMAND

ON THE

RISK FACTORS

MODIFIABLE

CHOLESTEROL

LEVEL

BP

SMOKING

OBESITY

NTG + VIAGRA

ETOH

HOMOCYSTEINE

UNMODIFIABLE

AGE

SEX

RACE

FAMILY HX

DIABETES

RISK RATIO

ANGINA PECTORIS

Temporary imbalance between O2 supply and demand

Symptom not a disease itself

Pain results from Lactic Acid

ANGINA PECTORIS

Stable Angina

Unstable angina

Silent Ischemia

Variant or Prinzmetal’s

Angina

STABLE ANGINA

Precipitated by exertion

Impaired blood delivery due to 75%

block

Predictable pattern

No change in symptoms over time

Pain relieved by rest or NTG

UNSTABLE ANGINA

Occurs at rest or without O2

demand

Preinfacrtion Angina

Can be > 90% blockage

Extreme pain

Last longer than 10 minutes and poor

relief from NTG or rest

SILENT ISCHEMIA

No pain

+ ECG

+ Cardiac Enzymes

VARIANT ANGINA

Arterial Spasms

No precipitating

factors

Rare

Occurs at rest

ASSESSMENT OF SXS

P = PRECIPITATES

Q = QUALITY

R = RADIATES

S = SEVERITY and

SYMPTOMS

T = TIMING

Characteristics of angina

CHEST PAIN

Different for men and women

: squeezing, fullness or

pressure in the center of your

chest.

: stabbing, pulsating, or sharp

Characteristics of angina

Vise squeezing chest

Heavy weight placed on their chest

Extend to the arm, especially the left arm,

neck, jaw, shoulder or back.

Nausea, fatigue, shortness of breath,

anxiety, sweating or dizziness

Crescendo effect – builds up and

gradually fades away

LAB TESTS

Cardiac Enzymes

Lipid profiles

CBC & Lytes

NTG Test

ECG

Stress Tests

Cardiac Scans (Thallium, MUGA, PET, LVEF)

Echo (TEE)

Cardiac Cath

NURSING

INTERVENTIONS

TEACH REFER

MEDICATIONS

ASA

NITRATES

BETA ADRENERGIC BLOCKERS

ACE INHIBITORS

CALCIUM CHANNEL BLOCKERS

ANGIOTENSIN II RECEPTOR BLOCKERS

THROMBOLYTIC THERAPY

ETIOLOGY